Financhill
Back

Intellia Therapeutics Vs. Expedia Group Industry Stock Comparison

Sell
43

NTLA
Intellia Therapeutics

Last Price:
25.16
Seasonality Move:
23.31%
Buy
62

EXPE
Expedia Group

Last Price:
124.63
Seasonality Move:
3.72%
Sell
43
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $25.15. The Score for NTLA is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Expedia Group (EXPE) is a Buy

Is Expedia Group a Buy, Sell or Hold?

  • The current Expedia Group [EXPE] share price is $124.61. The Score for EXPE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • EXPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $25.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.

EXPE Stock Price Chart

What is Expedia Group's stock price today?

  • The Expedia Group share price today is $124.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.17 Buy
Relative Strength Index (14 RSI): 56.19 Buy
Chaikin Money Flow: -750740 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.81 - 25.89) Buy
Bollinger Bands (100): (22.82 - 28.4) Sell

EXPE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.13 Buy
Relative Strength Index (14 RSI): 63.79 Buy
Chaikin Money Flow: 1409788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.39 - 120.53) Buy
Bollinger Bands (100): (118.56 - 142.94) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.09 Buy
20-day SMA: 24.04 Buy
50-day SMA: 23.64 Buy
200-day SMA: 27.83 Sell
8-day EMA: 24.48 Buy
20-day EMA: 24.08 Buy
50-day EMA: 24.38 Buy
200-day EMA: 28.73 Sell

EXPE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 122.19 Buy
20-day SMA: 116.08 Buy
50-day SMA: 122.11 Buy
200-day SMA: 126.7 Sell
8-day EMA: 121.84 Buy
20-day EMA: 119.09 Buy
50-day EMA: 121.93 Buy
200-day EMA: 125.12 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.00 per share, an increase this year of $0.28 per share, and a decrease next year of $0.38 per share.

Expedia Group Earnings Growth & EXPE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.48 per share, a decrease next quarter of $2.64 per share, an increase this year of $2.12 per share, and an increase next year of $2.83 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Expedia Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):